Haemoglobin adducts formed by aromatic amines in smokers: sources of inter-individual variability. by Ronco, G. et al.
Br. J. Cancer (1990), 61, 534-537
© Macmillan Press Ltd.,
Haemoglobin adducts formed by aromatic amines in smokers: sources of
inter-individual variability
G. Ronco', P. Vineis2, M.S. Bryant3*, P.L. Skipper3 & S.R. Tannenbaum3
'Unit ofEpidemiology, Local Health Administration TO I, via S. Francesco da Paola 31, 10123 Torino, Italy; 2Unit ofCancer
Epidemiology, Dipartimento di Scienze Biomediche e Oncologia Umana, University of Torino, via Santena 7, 10126 Torino, Italy;
3Department ofChemistry and Division of Toxicology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Summary In a previous study we found that aromatic amines, particularly 4-aminobiphenyl, formed haemo-
globin adducts at higher concentrations in the blood of smokers compared to non-smokers. We re-analyse here
data on haemoglobin adducts of 14 aromatic amines in order to ascertain if the inter-individual variability left
unexplained by tobacco smoking could be attributed to differences in individual metabolic patterns. For this
purpose we computed residuals from analysis of variance in order to adjust for individual smoking habits
(type and amount of tobacco). Residuals were correlated within two clearly distinct groups: one formed by
binuclear compounds (4-aminobiphenyl, 3-aminobiphenyl and 2-naphthylamine) and the other formed by all
other (i.e. mononuclear) compounds. Within each group, highly statistically significant correlation coefficients
were found, whereas compounds belonging to one group were not correlated to compounds in the other
group. These results can be interpreted as a suggestion that two different metabolic pathways exist, one for
binuclear and one for mononuclear arylamines, and that inter-individual differences in such pathways can
explain part of inter-individual variability in adduct levels. This interpretation is consistent with recent animal
experiments suggesting that there are different enzyme systems for the two classes of compounds.
In a previously published paper, Bryant et al. (1988) reported
that the quantity of haemoglobin adducts of 3-aminobi-
phenyl (3-ABP) and 4-aminobiphenyl (4-ABP) was related to
the number of cigarettes smoked and, for 4-ABP, to the kind
of tobacco (air- or flue-cured). However, the amount and
type of tobacco smoked left unexplained a considerable
proportion of inter-individual variability of haemoglobin
adducts of the 14 investigated arylamines, including 3-ABP,
4-ABP and 2-naphthylaine (2-NA).
4-ABP and 2-NA are well known bladder carcinogens, in
both humans and experimental animals (IARC, 1987). Of the
14 investigated arylamines, three were binuclear: 3-ABP and
4-ABP are formed by two benzene rings and 2-NA is a
naphthalene derivative; all the others have a single aromatic
ring.
Here we re-analyse the same data set in order to ascertain
whether the unexplained residual variability might be related
to differences in individual metabolic patterns. If individual
metabolic differences were responsible for part of the so
far unexplained inter-individual variability in haemoglobin
adducts and if chemically similar substances had, at least in
part, common metabolic pathways, then one would expect
the concentrations of adducts of similar amines to be cor-
related in the same individual, after allowing for amount and
type of tobacco smoked. In other words, if the hypothesis is
correct, after allowing for smoking habits, subjects showing
high levels of 4-ABP adducts should also have high levels of
3-ABP adducts and subjects showing low levels of 4-ABP
should also have low levels of 3-ABP.
Materials and methods
Subjects and materials included in the present analysis are
the same described in the previous report, which also des-
cribes laboratory procedures (Bryant et al., 1988).
Blood samples (10 ml) were collected from male volun-
teers: 25 non-smokers, 18 smokers of air-cured, black
tobacco and 43 smokers of flue-cured, blond tobacco (three
of these had also smoked a limited number of black tobacco
cigarettes in the recent past). All lived in the city of
Turin. Blood samples were blindly analysed for haemoglobin
adducts formed by 14 aromatic amines, using gas chrom-
atography-mass spectrometry.
Table I shows the distribution of smokers by type of
tobacco and number of cigarettes smoked the day before
blood sampling (three smokers of unfiltered cigarettes were
excluded). We excluded non-smokers and smokers belonging
to cells where only one subject was represented (those who
smoked 3, 8, 10, 12, 16, 17 or 40 blond tobacco cigarettes
and those who smoked 15 or 18 black tobacco cigarettes).
Only the remaining 49 subjects were included in the following
analyses. In fact, to study inter-individual variability not
explained by cigarettes consumption, at least two smokers of
the same amount and type of tobacco were necessary.
Statistical analysis
For each aromatic amine, we analysed data by one-way
analysis of variance, where every combination of number of
Table I Distribution of smokers by type of tobacco and number of
cigarettes smoked the day before blood sampling
Type oftobacco
Number ofcigarettes Blond Black
2 3 0
3 1 0
6 2 0
7 2 0
8 1 0
10 1 2
12 1 0
13 2 0
15 9 1
16 1 0
17 1 0
18 0 1
20 12 7
25 2 0
30 4 2
40 1 2
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cigarettes and type of tobacco represented a different level
of the explanatory variable (SAS GLM procedure (SAS Insti-
tute, 1987)); we computed the proportion of variability of
haemoglobin adducts explained by smoking, in terms of R2
and residuals from the model. Since we used a 'saturated'
model, so that residuals could not be dependent on a lack of
fit, the procedure used to compute residuals is equivalent to
compute the difference between the amount of adducts in
each subject and the mean of all subjects who smoked the
same number of cigarettes and kind of tobacco. We repeated
this procedure for each of the 14 different aromatic amines
investigated.
Residuals of adduct concentration (pg adduct per g haemo-
globin) fitted log normal distributions much better than nor-
mal distributions and we therefore used logarithms of adduct
concentrations in the analyses.
We computed the correlation matrix of the residuals
obtained for each of the 14 aromatic amines, and analysed
it by the principal components method (SAS PRINCOMP
procedure (SAS Institute, 1987)). The principal components
analysis (PCA) is a multivariable method designed to explain
the relationships among several correlated variables in terms
of a few conceptually meaningful, independent factors. PCA
determines these factors (i.e. principal components) in such
a way that they explain as much of the total variation in
the data as possible, with as few of these factors as possible
(Kleinbaum & Kupper, 1978). Principal components are
weighted combinations of the variables: a high weight
indicates a high correlation between the variable and the
principal component. The proportion of total variance ex-
plained by each factor is equal to the variance of each factor
divided by the sum of the variances of the residuals of all
examined arylamines. Clearly such proportion increases with
(i) an increasing number of different compounds related to
the factor and (ii) a stronger association between single com-
pounds and the factor. It should not be confused with the
proportion of variability of the concentration of each adduct
explained by smoking habits (the R2 for each compound in
Table II).
Results
Table II reports the proportion of inter-individual variability
(among smokers) for haemoglobin adducts of single aromatic
amines explained by smoking habits in terms of R2: from 91
to 46% of variability, depending on the substance, is left
unexplained by the kind of tobacco and number of cigarettes
smoked the day before blood collection.
Table III shows the correlation matrix between the resi-
duals of the 14 aromatic amines, measured as log (adduct
concentration). Residuals of 3-ABP, 4-ABP and 2-NA (the
binuclear amines) show high reciprocal correlation coeffic-
ients, but low correlation with residuals of the other,
mononuclear, amines (except P-toluidine). In contrast, the
residuals of all other substances are in general highly inter-
correlated but they show independence from residuals of the
first group of substances. Nearly all the mono-mono and
bi-bi correlation coefficients are above 0.4 and nearly all the
mono-bi correlations are below 0.2. Of the correlations
between different binuclear amines all three are statistically
significant (P<0.05), and of the correlations between
different mononuclear amines, 49 out of 54 are statistically
significant, whereas of the 33 correlations between one mono-
and one binuclear amine, only two are significant.
In Table IV, PCA (see Statistical analysis) shows that the
first factor explains 49% of total variance and is related to all
substances but 3-ABP, 4-ABP and 2-NA; the second factor
explains a further 16% of total variance and is related to
3-ABP, 4-ABP and 2-NA, whereas coefficients for all other
amines (except P-toluidine) are negative or close to zero.
We repeated the analysis including blond tobacco smokers
only (36 subjects) and results did not change.
Table II Proportion of variation in adduct levels (R2) explained by
type oftobacco and number ofcigarettes smoked theday before blood
sampling
Substance R2
4-aminobiphenyl 0.52
3-aminobiphenyl 0.33
2-naphthylamine 0.19
O-toluidine 0.20
M-toluidine 0.09
P-toluidine 0.15
2,4-dimethylaniline 0.38
2,6-dimethylaniline 0.52
2,3-dimethylaniline 0.29
3,5-dimethylaniline 0.13
3,4-dimethylaniline 0.24
2,5-dimethylaniline 0.31
3-ethylaniline 0.26
2-ethylaniline 0.31
Discussion
We previously observed that the type and amount of tobacco
smoked were associated with haemoglobin adduct levels
formed by a few aromatic amines, particularly 4-aminobi-
phenyl (Bryant et al., 1988). This observation was relevant,
because 4-ABP is a powerful bladder carcinogen, and smok-
ers, particularly of black, air-cured tobacco, are at high risk
of bladder cancer (Vineis et al., 1984). However, we noticed
that the inter-individual variability in adduct levels unex-
plained by type and amount of tobacco smoked was
considerable (between 84% and 46% according to the sub-
stance). It must be stressed that the proportion of variability
explained by smoking habits, as reported in Table II, is likely
to be an overestimation since the model is saturated.
We performed, therefore, an analysis of residual variabil-
ity. Our hypothesis was that individual metabolic differences,
as expressed by the correlation among adducts formed by different aromatic amines, could further explain part of the
inter-individual variability. The results are clearly in agree-
ment with such a hypothesis, since the correlation among a
group of residuals explains 49% of the total variance of
residuals, and the correlation among residuals of a second
group explains a further 16% (Table IV). Moreover, the
variables contributing to the first factor are all mononuclear
aromatic amines, while those related to the second factor
are binuclear amines (3-ABP, 4-ABP, 2-NA). Residuals of
compounds from one group (e.g. mononuclear) are highly correlated to residuals of the other amines within the same
group but are independent from residuals of compounds of
the other group. In other words, subjects who have levels of
one arylamine higher than expected have higher levels of the
other compounds belonging to the same structural group too.
One possible interpretation of this finding is that two
different metabolic pathways are involved, one for mono-
nuclear and the other for binuclear aromatic amines, and
that inter-individual variability is present for each of this
pathways. The possibility that the levels of haemoglobin
or DNA adducts in humans are influenced by metabolic
patterns (including activation and deactivation of chemicals
and DNA repair) has already been put forward. For exam-
ple, Nowak et al. (1988) recently reported that, among 86
first-degree relatives of 15 families, inter-familial variations
for benzo(a)pyrene DNA adducts were higher than intra-
familial variations, thus suggesting a genetic component. The
activities of enzymes, such as hydrocarbon hydroxylase
(Guengerich, 1988) or N-acetyltransferase (Schulte, 1988), involved in the activation or deactivation of carcinogenic
compounds are known to be genetically determined, in the
sense that genotypic polymorphisms exist in human popula-
tions. Acquired inter-individual differences are also possible,
due to enzyme induction.
In the case of aromatic amines, it is plausible that different536 G. RONCO et al.
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Table IV Principal components analysis of the residuals of the 14
aromatic amines
Substance Factor 1 Factor 2 Factor 3 Factor 4
4-ABPa 0.05 0.29 0.58 0.02
3-ABP 0.05 0.50 0.23 -0.16
2-NA 0.00 0.51 0.08 0.18
O-TOL 0.22 0.12 0.04 0.72
M-TOL 0.33 0.12 0.05 -0.00
P-TOL 0.22 0.39 -0.22 -0.19
2,4-DIMET 0.27 0.06 -0.37 0.16
2,6-DIMET 0.22 -0.16 0.45 -0.38
2,3-DIMET 0.33 -0.20 0.14 -0.07
3,5-DIMET 0.34 -0.02 -0.18 -0.20
3,4-DIMET 0.34 0.08 -0.21 -0.17
2,5-DIMET 0.31 -0.28 0.18 0.14
3-ETHYL 0.36 0.06 -0.15 -0.14
2-ETHYL 0.30 -0.22 0.21 0.30
Proportion of 49% 16% 10% 7%
total
variance
explained by
each factor
Weightsofresidualsofeachsubstancein thefirstfourfactors, seetext
fordefinitionoffactorsand forthemeaningofweights.aSeeTable11 for
the meaning of abbreviations.
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metabolic pathways exist for mono- and binuclear com-
pounds respectively. In particular, a single cytochrome P-450
is considered now to be responsible for N-hydroxylation of
binuclear aromatic amines (Butler et al., 1990). Experiments
have been conducted to determine the inducibility ofcovalent
binding by continuous adminstration of either 2,6-dimethyl-
aniline or 2-acetylaminofluorene to rats (Short & Hardy,
1989). An increase in covalent binding in the target organ
was seen for 2,6-dimethylaniline while a decrease in the target
organ was observed for 2-acetylaminofluorene. This can be
interpreted as a difference in the type of metabolism induced
by the monocyclic versus the policyclic aromatic amines and
supports the hypothesis that there are different enzyme
systems for these two classes of compounds.
The following alternative hypotheses can be considered.
1. Misclassification of the number of cigarettes smoked. In
fact the reported number of cigarettes tends to concentrate
on the values of 15 and 20. However, this phenomenon
should have given, as a result, an artifactual correlation of
residuals of all amines; it cannot explain the existence of two
groups of compounds with different behaviours.
2. Exposure to sources of aromatic amines other than
tobacco smoking. However, none of the subjects was clearly
exposed to aromatic amines for occupational or other
reasons other than smoking. In addition, in order to justify
this interpretation some subjects should have been exposed to
mononuclear amines only and others to binuclear amines
only, which is totally implausible.
3. Measurement errors might be reciprocally correlated
within, but not between, the two groups of substances. This,
however, seems to be a very implausible explanation of the
findings, considering that many correlation coefficients are
higher than 0.5 and a few are higher than 0.9. In order to
justify a correlation coefficient of 0.5, variance due to
measurement error should be as large as the true variance of
adduct concentrations, and to justify a correlation coefficient
of 0.9 it should be nine times as large. Clearly this is very
unlikely.
In conclusion, none of the considered alternative hypo-
theses seems to be able to explain completely the findings,
even if they could account for part of them. On the basis of
the present results it is plausible that inter-individual
metabolic differences affect internal levels of exposure to
carcinogens. Such metabolic patterns might be relevant to the
individual risk of cancer. However, this suggestion needs to
be verified in further epidemiological and experimental
studies.
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